ZMPSTE24 and metabolic syndrome: Genetic mutations, affecting either LMNA or the associated processing enzyme ZMPSTE24, have been shown to have a prevalence of 3 % in a small cohort of patients with metabolic syndrome [74] raising the possibility that mutations in the LMNA gene may contribute, or predispose, an affected individual to the metabolic syndrome.